Advancements in Novel Drug Formulation: Strategies for Enhanced Bioavailability and Therapeutic Efficacy

Abstract

The process of drug formulation and development has evolved significantly over the past decades, aiming to improve bioavailability, patient compliance, and therapeutic efficacy. Novel drug delivery systems such as nanoparticles, liposomes, and polymeric micelles have been extensively researched to overcome solubility and stability challenges associated with conventional drug formulations. This paper critically reviews current advancements in drug formulation strategies, emphasizing formulation optimization, excipient selection, and innovative technologies that enhance drug absorption and controlled release. Furthermore, regulatory perspectives and quality control measures essential for formulation development are discussed. Case studies on poorly soluble drugs illustrate how formulation modifications can substantially improve pharmacokinetic profiles. Finally, the paper highlights future trends in formulation science, including personalized medicine and smart drug delivery systems, demonstrating the integration of nanotechnology, molecular modeling, and patient-centric approaches in modern pharmaceutical research.

KEYWORDS: Drug Formulation, Bioavailability, Nanotechnology, Controlled Release, Pharmaceutical Research